Prelude Therapeutics Incorporated : Announces First Quarter 2023 Financial Results and Operations Update - Form 8-K

Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update


Eight abstracts presented at AACR 2023 demonstrate progress of the pipeline


... | May 8, 2023

Related Keywords

United States ,American ,Kris Vaddi ,Helen Shik ,Lindsey Trickett ,Shik Communications ,Inhibitor Program ,Prelude Therapeutics Incorporated Nasdaq ,American Association For Cancer Research Annual Meeting ,Twitter ,Protein Degrader Program ,Program Updates ,Exchange Commission ,Development Rd Expenses ,Linkedin ,Prelude Therapeutics Announces First Quarter ,Operations Update ,Therapeutics Incorporated ,Chief Executive Officer ,Cancer Research Annual Meeting ,Upcoming Milestones ,Next Generation ,Cash Equivalents ,Marketable Securities ,Private Securities Litigation Reform Act ,Months Ended March ,Investor Relations ,Prelude Therapeutics Incorporated Stock Exchange ,News ,Information ,Press Release ,Prelude ,Herapeutics ,Nnounces ,First ,Quarter ,023 ,Financial ,Results ,End ,Operations ,Flight ,Abstracts ,Resented ,It ,Racr ,Emonstrate ,Progress ,F ,He Prld Us74065p1012 ,